Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis

mBio

Volumn 7, Issue 6, 2016, Pages

  Perdomo, Carolina ^a   Zedler, Ulrike ^a   Kühl, Anja A ^b   Lozza, Laura ^a   Saikali, Philippe ^a   Sander, Leif E ^b   Vogelzang, Alexis ^a   Kaufmann, Stefan H E ^a   Kupz, Andreas ^a,c  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; IMMUNOLOGICAL ADJUVANT;

AIRWAY CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; LUNG INFILTRATE; LUNG TUBERCULOSIS; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ADOPTIVE TRANSFER; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; TREATMENT OUTCOME; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADOPTIVE TRANSFER; ANIMALS; BCG VACCINE; DISEASE MODELS, ANIMAL; IMMUNOLOGIC MEMORY; INJECTIONS, SUBCUTANEOUS; LUNG; MICE; T-LYMPHOCYTES; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 85007597339     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01686-16     Document Type: Article

References (49)

1. Calmette A. 1927. La vaccination préventive contre la tuberculose par le ‘BCG’. Masson & Co., Paris, France.
2. Trunz BB, Fine P, Dye C. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a metaanalysis and assessment of cost-effectiveness. Lancet 367: 1173-1180. http://dx.doi.org/10.1016/S0140-6736(06)68507-3.
3. WHO. 2015, Global tuberculosis report. World Health Organization, Geneva, Switzerland.
4. Kaufmann SH. 2013. Tuberculosis vaccines: time to think about the next generation. Semin Immunol 25: 172-181. http://dx.doi.org/10.1016/ j.smim.2013.04.006.
5. StopTB Partnership. 2014. StopTB Partnership 2014 annual report. United Nations Office for Project Services, U.N. City, Copenhagen, Den-mark. http://www.stoptb.org/assets/documents/resources/publications/ annualreports/STOPTB_annualeport_2014_web.pdf.
6. Ottenhoff TH, Kaufmann SH. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8: e1002607. http:// dx.doi.org/10.1371/journal.ppat.1002607.
7. + T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 171: 4689-4699. http://dx.doi.org/10.4049/ jimmunol.171.9.4689.
8. Andersen P, Smedegaard B. 2000. CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice. Infect Immun 68: 621-629. http://dx.doi.org/10.1128/IAI.68.2.621-629.2000.
9. Beverley PC, Sridhar S, Lalvani A, Tchilian EZ. 2014. Harnessing local and systemic immunity for vaccines against tuberculosis. Mucosal Immunol 7: 20-26. http://dx.doi.org/10.1038/mi.2013.99.
10. Monteiro-Maia R, de Pinho RT. 2014. Oral bacillus Calmette-Guerin vaccine against tuberculosis: why not? Mem Inst Oswaldo Cruz 109: 838-845. http://dx.doi.org/10.1590/0074-0276140091.
11. Manjaly Thomas ZR, McShane H. 2015. Aerosol immunisation for TB: matching route of vaccination to route of infection. Trans R Soc Trop Med Hyg 109: 175-181. http://dx.doi.org/10.1093/trstmh/tru206.
12. Aguilo N, Toledo AM, Lopez-Roman EM, Perez-Herran E, Gormley E, Rullas-Trincado J, Angulo-Barturen I, Martin C. 2014. Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination. Clin Vaccine Immunol 21: 594-597. http://dx.doi.org/10.1128/CVI.00700-13.
13. Chen X, Xiu F, Horvath CN, Damjanovic D, Thanthrige-Don N, Jeyanathan M, Xing Z. 2012. Regulation of TB vaccine-induced airway luminal T cells by respiratory exposure to endotoxin. PLoS One 7: e41666. http://dx.doi.org/10.1371/journal.pone.0041666.
14. Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrançois L, Farber DL. 2011. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 187: 5510-5514. http://dx.doi.org/10.4049/jimmunol.1102243.
15. Horvath CN, Shaler CR, Jeyanathan M, Zganiacz A, Xing Z. 2012. Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. Mucosal Immunol 5: 420-431. http://dx.doi.org/10.1038/mi.2012.19.
16. Unsoeld H, Pircher H. 2005. Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7. J Virol 79: 4510-4513. http:// dx.doi.org/10.1128/JVI.79.7.4510-4513.2005.
17. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. http://dx.doi.org/10.1038/44385.
18. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. 2009. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 10: 524-530. http://dx.doi.org/10.1038/ni.1718.
19. Kaushal D, Foreman TW, Gautam US, Alvarez X, Adekambi T, Rangel-Moreno J, Golden NA, Johnson AM, Phillips BL, Ahsan MH, Russell-Lodrigue KE, Doyle LA, Roy CJ, Didier PJ, Blanchard JL, Rengarajan J, Lackner AA, Khader SA, Mehra S. 2015. Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis. Nat Commun 6: 8533. http:// dx.doi.org/10.1038/ncomms9533.
20. Aguilo N, Alvarez-Arguedas S, Uranga S, Marinova D, Monzón M, Badiola J, Martin C. 2016. Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism. J Infect Dis 213: 831-839. http:// dx.doi.org/10.1093/infdis/jiv503.
21. Lalvani A. 2004. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 38: 757-759. http://dx.doi.org/10.1086/381763.
22. + T cell migration to the lung during parainfluenza virus infection. J Immunol 183: 4378-4384. http://dx.doi.org/10.4049/ jimmunol.0902022.
23. Wu T, Hu Y, Lee YT, Bouchard KR, Benechet A, Khanna K, Cauley LS. 2014. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol 95: 215-224. http://dx.doi.org/10.1189/jlb.0313180.
24. Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D. 2014. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346: 98-101. http:// dx.doi.org/10.1126/science.1254536.
25. Gebhardt T, Mueller SN, Heath WR, Carbone FR. 2013. Peripheral tissue surveillance and residency by memory T cells. Trends Immunol 34: 27-32. http://dx.doi.org/10.1016/j.it.2012.08.008.
26. Cauley LS, Lefrançois L. 2013. Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol 6: 14-23. http://dx.doi.org/10.1038/mi.2012.96.
27. + tissue-resident memory T cells of skin. Nat Immunol 14: 1294-1301. http://dx.doi.org/10.1038/ni.2744.
28. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10: 595-602. http://dx.doi.org/10.1038/ni.1731.
29. Lee LN, Ronan EO, de Lara C, Franken KL, Ottenhoff TH, Tchilian EZ, Beverley PC. 2011. CXCR6 is a marker for protective antigenspecific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis. Infect Immun 79: 3328-3337. http://dx.doi.org/10.1128/IAI.01133-10.
30. Giri PK, Sable SB, Verma I, Khuller GK. 2005. Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis. FEMS Immunol Med Microbiol 45: 87-93. http://dx.doi.org/10.1016/j.femsim.2005.02.009.
31. Hosseini M, Dobakhti F, Pakzad SR, Ajdary S. 2015. Immunization with single oral dose of alginate-encapsulated BCG elicits effective and longlasting mucosal immune responses. Scand J Immunol 82: 489-497. http:// dx.doi.org/10.1111/sji.12351.
32. Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL. 2001. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 193: 981-986. http://dx.doi.org/10.1084/jem.193.8.981.
33. Turner DL, Farber DL. 2014. Mucosal resident memory CD4 T cells in protection and immunopathology. Front Immunol 5: 331. http:// dx.doi.org/10.3389/fimmu.2014.00331.
34. Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, Carbone FR, Gebhardt T. 2015. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J Immunol 194: 2059-2063. http://dx.doi.org/10.4049/ jimmunol.1402256.
35. Ray SJ, Franki SN, Pierce RH, Dimitrova S, Koteliansky V, Sprague AG, Doherty PC, de Fougerolles AR, Topham DJ. 2004. The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20: 167-179. http://dx.doi.org/10.1016/S1074-7613(04)00021-4.
36. Slütter B, Pewe LL, Kaech SM, Harty JT. 2013. Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus. Immunity 39: 939-948. http://dx.doi.org/10.1016/ j.immuni.2013.09.013.
37. Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, Yethon JA, Farokhzad OC, Langer R, Starnbach MN, von Andrian UH. 2015. Vaccines. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348: aaa8205. http://dx.doi.org/10.1126/ science.aaa8205.
38. Mueller SN, Mackay LK. 2016. Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol 16: 79-89. http:// dx.doi.org/10.1038/nri.2015.3.
39. Couper KN, Blount DG, Riley EM. 2008. IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777. http://dx.doi.org/10.4049/jimmunol.180.9.5771.
40. Laidlaw BJ, Cui W, Amezquita RA, Gray SM, Guan T, Lu Y, Kobayashi Y, Flavell RA, Kleinstein SH, Craft J, Kaech SM. 2015. Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells. Nat Immunol 16: 871-879. http://dx.doi.org/10.1038/ni.3224.
41. Kupz A, Zedler U, Stäber M, Perdomo C, Dorhoi A, Brosch R, Kaufmann SH. 2016. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo. J Clin Invest 126: 2109-2122. http://dx.doi.org/10.1172/JCI84978.
42. Rao M, Vogelzang A, Kaiser P, Schuerer S, Kaufmann SH, Gengenbacher M. 2013. The tuberculosis vaccine candidate bacillus Calmette-Guerin DeltaureC:: hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice. PLoS One 8: e78966. http://dx.doi.org/10.1371/journal.pone.0078966.
43. Derrick SC, Kolibab K, Yang A, Morris SL. 2014. Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice. Clin Vaccine Immunol 21: 1443-1451. http://dx.doi.org/10.1128/CVI.00394-14.
44. Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DWH, Lenz LL. 2011. Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J Vis Exp. http://dx.doi.org/10.3791/2702: 10.3791/2702.
45. Nouailles G, Dorhoi A, Koch M, Zerrahn J, Weiner J III, Faé KC, Arrey F, Kuhlmann S, Bandermann S, Loewe D, Mollenkopf HJ, Vogelzang A, Meyer-Schwesinger C, Mittrücker HW, McEwen G, Kaufmann SH. 2014. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest 124: 1268-1282. http://dx.doi.org/10.1172/JCI72030.
46. + T cells are responsible for the recombinant bacillus Calmette-Guerin DeltaureC:: hly vaccine’s superior protection against tuberculosis. J Infect Dis 210: 1928-1937. http://dx.doi.org/10.1093/infdis/jiu347.
47. + T-cell stimulation in response to Bacille Calmette-Guerin. Eur J Immunol 44: 80-92. http:// dx.doi.org/10.1002/eji.201343797.
48. Thome JJ, Bickham KL, Ohmura Y, Kubota M, Matsuoka N, Gordon C, Granot T, Griesemer A, Lerner H, Kato T, Farber DL. 2016. Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues. Nat Med 22: 72-77. http:// dx.doi.org/10.1038/nm.4008.
49. Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, Mathema B, Ramaswamy SV, Walther G, Steyn LM, Barry CE III, Bekker LG. 2003. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 71: 7099-7108. http://dx.doi.org/10.1128/IAI.71.12.7099-7108.2003.